Roche Calls For U.S. Contract To Guarantee Tamiflu Stockpile
This article was originally published in The Pink Sheet Daily
HHS is in discussions to purchase enough of the influenza treatment to cover a total of 3% of the U.S. population, Roche tells House hearing on pandemic preparedness. Other countries already have purchase commitments that would cover 20% to 40% of their populations.
You may also be interested in...
Securities & Exchange Commission regulations on revenue recognition are preventing childhood vaccine manufacturers from selling product to a government stockpile. Rep. Waxman declares support for a special exemption for vaccine makers.
The agency has seen "tremendous progress" in the move toward electronic product codes and use of radio-frequency identification, FDA says in its annual counterfeit drug update. FDA initiated 58 counterfeit drug investigations in 2004, up from 30 the previous year.
Smallpox vaccination should be reinstated for the entire U.S. population, MIT’s Deutch suggests. Additional research on other biological threats is called for; federal funding is recommended instead of relying on industry initiative, due to lack of market incentives.